G1 Therapeutics Inc.

NASDAQ: GTHX · Real-Time Price · USD
7.16
0.01 (0.14%)
At close: Sep 17, 2024, 9:56 PM

G1 Therapeutics Revenue Breakdown

Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
License Revenue 36.17M 19.96M 20.36M
License Revenue Growth +81.16% -1.93% n/a
Product Revenue 46.34M 31.34M 11.12M
Product Revenue Growth +47.89% +181.81% n/a

Operating Expense Breakdown

Period Ending Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016
Selling, General, and Administrative Revenue 13.61M 15.13M 15.17M 16.78M 17.43M 21.75M 23.56M 24.43M 25.72M 26.71M 23.22M 24.27M 25.24M 22.97M 24.26M 18.41M 14.43M 11.39M 12.06M 11.08M 9.09M 7.8M 7.01M 4.95M 3.27M 3.38M 2.21M 1.88M 1.71M 1.29M 1.26M 918K 975K 2.07M
Selling, General, and Administrative Revenue Growth -10.03% -0.26% -9.62% -3.73% -19.86% -7.66% -3.58% -4.99% -3.72% +15.04% -4.33% -3.84% +9.87% -5.32% +31.76% +27.59% +26.73% -5.59% +8.82% +21.87% +16.57% +11.30% +41.62% +51.44% -3.26% +53.13% +17.65% +9.52% +32.29% +2.65% +37.32% -5.85% -53.01% n/a
Research and Development Revenue 5.74M 7.32M 7.38M 8.81M 12.04M 15.48M 16.59M 19.58M 20.84M 26.3M 19.79M 21.14M 18.75M 16.54M 16.37M 17.93M 18.53M 20.43M 24.49M 22.94M 23.49M 18.08M 19.08M 15.87M 18.39M 17.35M 15.07M 14.05M 13.67M 11.08M 9.14M 5.7M 6.45M 3.87M
Research and Development Revenue Growth -21.59% -0.84% -16.24% -26.82% -22.22% -6.67% -15.29% -6.05% -20.76% +32.92% -6.40% +12.75% +13.37% +1.01% -8.69% -3.23% -9.31% -16.57% +6.76% -2.33% +29.92% -5.23% +20.19% -13.66% +5.98% +15.07% +7.26% +2.83% +23.30% +21.25% +60.51% -11.76% +66.71% n/a